NCT03618862View on ClinicalTrials.gov

Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

January 18, 2019

Primary Completion Date

July 16, 2021

Study Completion Date

July 16, 2021

Conditions
Hiv
Interventions
BIOLOGICAL

Blood sampling

Peripheral venous blood collection of 56 mL during a sampling required by routine monitoring of human immunodeficiency virus infection.

Trial Locations (1)

69004

Service des maladies infectieuses et tropicales - Hôpital de la Croix Rousse - GHN, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03618862 - Study of the Effects of Farnesoid X Receptor (FXR) Ligands on the Reactivation of Latent Provirus | Biotech Hunter | Biotech Hunter